Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma

References

1. 1.↵
   2. Chen W,
   3. Zheng R,
   4. Baade PD,
   5. Zhang S,
   6. Zeng H,
   7. Bray F, et al.

   Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66: 115–32.

   OpenUrlCrossRefPubMed
2. 2.↵
   2. Kim DS,
   3. Kim BW,
   4. Hatano E,
   5. Hwang S,
   6. Hasegawa K,
   7. Kudo A, et al.

   Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korea-Japan multicenter study. Ann Surg. 2020; 271: 913–21.

   OpenUrl
3. 3.↵
   2. Qin LX,
   3. Tang ZY.

   Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol. 2003; 9: 385–91.

   OpenUrlPubMed
4. 4.↵
   2. Xiangji L,
   3. Weifeng T,
   4. Bin Y,
   5. Chen L,
   6. Xiaoqing J,
   7. Baihe Z, et al.

   Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg. 2009; 394: 1033–9.

   OpenUrlPubMed
5. 5.↵
   2. Zhou X,
   3. Wang J,
   4. Tang M,
   5. Huang M,
   6. Xu L,
   7. Peng Z, et al.

   Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge. BMC Cancer. 2020; 20: 54.

   OpenUrl
6. 6.↵
   2. Lau WY,
   3. Leung KL,
   4. Leung TW,
   5. Ho S,
   6. Chan M,
   7. Liew CK, et al.

   Obstructive jaundice secondary to hepatocellular carcinoma. Surg Oncol. 1995; 4: 303–8.

   OpenUrlPubMed
7. 7.↵
   2. Keung EZ,
   3. Gershenwald JE.

   The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018; 18: 775–84.

   OpenUrl
8. 8.↵
   2. Kudo M,
   3. Chung H,
   4. Osaki Y.

   Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003; 38: 207–15.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   2. Kitai S,
   3. Kudo M,
   4. Izumi N,
   5. Kaneko S,
   6. Ku Y,
   7. Kokudo N, et al.

   Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey. Dig Dis. 2014; 32: 717–24.

   OpenUrl
10. 10.↵
    2. Bruix J,
    3. Reig M,
    4. Sherman M.

    Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016; 150: 835–53.

    OpenUrlCrossRefPubMed
11. 11.↵
    2. Ueda M,
    3. Takeuchi T,
    4. Takayasu T,
    5. Takahashi K,
    6. Okamoto S,
    7. Tanaka A, et al.

    Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi. Hepatogastroenterology. 1994; 41: 349–54.

    OpenUrlPubMed
12. 12.↵
    Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 3rd English ed. Tokyo, Japan: Kanehara & Co., Ltd; 2010.
13. 13.↵
    2. Lau W,
    3. Leung K,
    4. Leung TW,
    5. Liew CT,
    6. Chan MS,
    7. Yu SC, et al.

    A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg. 1997; 225: 281–5.

    OpenUrlCrossRefPubMed
14. 14.↵
    2. An J,
    3. Lee KS,
    4. Kim KM,
    5. Park DH,
    6. Lee SS,
    7. Lee D, et al.

    Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion. Clin Mol Hepatol. 2017; 23: 160–9.

    OpenUrl
15. 15.↵
    2. Navadgi S,
    3. Chang CC,
    4. Bartlett A,
    5. McCall J,
    6. Pandanaboyana S.

    Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus. HPB (Oxford). 2016; 18: 312–6.

    OpenUrl
16. 16.↵
    2. Yamamoto S,
    3. Hasegawa K,
    4. Inoue Y,
    5. Shindoh J,
    6. Aoki T,
    7. Sakamoto Y, et al.

    Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg. 2015; 261: e123–5.

    OpenUrl
17. 17.↵
    2. Lin Z,
    3. Han M,
    4. Zhou Z.

    Prognosis for patients with hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BTT) after surgical treatment. Biosci Trends. 2019; 13: 77–85.

    OpenUrl